This week Mannatech is celebrating a major feat of research and development. The nutrition company has received its 100th patent, issued in Korea for its PhytoMatrix dietary supplement formulation.
While industry giants such as Amway and Mary Kay—with more than 1,100 and 800 patents, respectively—have built up large patent portfolios, Mannatech is an aberration among mid-sized companies both in direct selling and in the nutritional supplement industry. Averaging nearly five patent awards per year, Mannatech has outpaced many larger, older brands.
Mannatech guards its core technology and formulations to keep its products from becoming “mere commodities” in the market, says Dr. Rob Sinnott, CEO and Chief Science Officer. “We believe this approach helps our Associates to build a successful business in major global markets around the world.”
Mannatech’s comprehensive quality assurance program complies with the U.S. Food and Drug Administration’s current Good Manufacturing Practices. Many of the company’s products have also attained third-party certification through NSF International, which imposes rigorous testing and compliance standards. In addition to its PhytoMatrix product, Mannatech has patented technology pertaining to its Ambrotose, Ambrotose AO and GI-ProBalance formulations.